Efficacy and safety of the association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease …
E Salvadori, A Poggesi, I Donnini, V Rinnoci, G Chiti… - Drugs & aging, 2021 - Springer
Background No approved treatment is available for patients with vascular cognitive
impairment (VCI) due to cerebral small vessel disease (SVD). Objective The CONIVaD …
impairment (VCI) due to cerebral small vessel disease (SVD). Objective The CONIVaD …
The role of association between the cholinergic precursor choline alphoscerate and sulodexide in vascular dementia
A Di Salvo - Geriatric Care, 2021 - pagepressjournals.org
Dementia is a syndrome of acquired intellectual deficit resulting in significant impairment of
social or occupational functioning. Vascular dementia (VaD) is the second most common …
social or occupational functioning. Vascular dementia (VaD) is the second most common …